Api m 6: a new bee venom allergen.

Area of Science:

• Allergen characterization
• Immunology
• Protein biochemistry

Background:

• Understanding allergen structure is key for developing diagnostic and therapeutic tools for allergic diseases.
• Bee venom (BV) hypersensitivity affects many individuals, necessitating further research into its causative agents.

Purpose of the Study:

• To identify and characterize a novel, low-molecular-weight allergen from bee venom (BV) that binds to IgE antibodies.
• To investigate the immunological response elicited by this newly identified allergen.

Main Methods:

• Bee venom proteins were fractionated using size exclusion chromatography and High-Performance Liquid Chromatography (HPLC).
• IgE binding was assessed via immunoblotting, and T-cell response was measured using proliferation assays.
• Amino acid sequencing was performed using Edman degradation and mass spectrometry.

Main Results:

• A novel allergen, Api m 6, was identified, recognized by IgE in 42% of bee venom-hypersensitive patients.
• Api m 6 induced proliferation in peripheral blood mononuclear cells (PBMCs) from both hypersensitive patients and a control subject.
• Four isoforms of Api m 6 were characterized, sharing a common core structure but differing in terminal sequences, with no significant homology to known proteins.

Conclusions:

• A new bee venom allergen, Api m 6, has been identified and sequenced.
• Api m 6 elicits a robust IgE and T-cell response in a significant portion of bee venom-hypersensitive individuals.
• Api m 6 represents a potential target for improved diagnostics and immunotherapy for bee venom allergy.